Related Experiment Videos
Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study
B J Broker1, D Rosen, J Amsberry
1Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, USA.
The Laryngoscope
|December 1, 1996
Summary
Interferon-gamma (IFN-G) injections may help prevent keloid recurrence after surgical excision. This double-blind trial investigated IFN-G as an adjunct therapy for keloid management, showing promising results in reducing abnormal collagen overproduction.
Area of Science:
- Dermatology
- Wound Healing Research
- Collagen Biology
Background:
- Keloids result from abnormal wound healing with excessive collagen deposition.
- Histologically, keloids feature haphazardly arranged, thick collagen bundles compared to normal scars.
- Prior studies suggest intralesional interferon-gamma (IFN-G) may reduce keloid size.
Purpose of the Study:
- To evaluate the efficacy of intralesional interferon-gamma (IFN-G) as an adjunct to surgical keloid excision.
- To determine if IFN-G can prevent keloid recurrence post-excision.
Main Methods:
- Double-blind, placebo-controlled trial design.
- Patients with multiple keloids underwent surgical excision.
- Post-excision, keloids were treated with local injections of either IFN-G or a placebo.
Main Results:
- The study aimed to assess the impact of IFN-G on keloid recurrence rates.
- Comparison between the IFN-G group and the placebo group was conducted.
Conclusions:
- IFN-G demonstrates potential as an adjunctive therapy for keloid treatment.
- Further research is warranted to confirm IFN-G's role in preventing keloid recurrence after surgery.